10031-RT-02 Results of reactor-based BNCT for 44 cases of recurrent and refractory high-grade meningiomas and road to accelerator based BNCT

Introduction: High-grade meningioma (HGM) is difficult clinical entity to treat. Especially recurrent HGM after some radiotherapy has very miserable prognosis. For example median overall survival (mOS) of recurrent HGM after radiotherapy is reported as 2 years. We applied tumor-selective particle ra...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neurooncol Adv
Hlavní autoři: Miyatake, Shin-Ichi, Kawabata, Shinji, Wanibuchi, Masahiko, Takai, Satoshi, Takeuchi, Koji, Ono, Koji, Ko, Naonori, Sakurai, Yoshinori, Tanaka, Hiroki, Suzuki, Minoru
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Supplement Abstracts
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7699070/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa143.047
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky